Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 3506
  • Home
  • Print this page
  • Email this page

   Table of Contents      
LETTER TO EDITOR
Year : 2010  |  Volume : 58  |  Issue : 4  |  Page : 346-347

Authors' reply


1 Vittala International Institute of Ophthalmology & Prabha Eye Clinic and Research Center, Bangalore, India
2 Santosh Diagnostic Centre, Bangalore, India
3 Department of Biostatistics, National Institute of Mental Health Sciences, Bangalore, India

Date of Web Publication7-Jun-2010

Correspondence Address:
Kalpana Babu
Prabha Eye Clinic & Research Center, 504, 40th Cross, Jayanagar 8th Block, Bangalore-560 070
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

How to cite this article:
Babu K, Satish V, Satish S, SubbaKrishna D K, Abraham MP, Murthy KR. Authors' reply. Indian J Ophthalmol 2010;58:346-7

How to cite this URL:
Babu K, Satish V, Satish S, SubbaKrishna D K, Abraham MP, Murthy KR. Authors' reply. Indian J Ophthalmol [serial online] 2010 [cited 2020 May 27];58:346-7. Available from: http://www.ijo.in/text.asp?2010/58/4/346/64124

Dear Editor,

We wish to thank Chabblani [1] for their interest in this article. [2]

We would like to clarify a few points raised in their letter.

In all patients with a positive quantiferon TB gold test, a detailed systemic evaluation by a chest physician with special interest in tuberculosis followed up with basic laboratory investigations like Mantoux test, ESR, Chest X-ray and liver enzymes were done before labeling them false positives.

It has been mentioned in our article in the 'Materials and methods' that history of prior BCG vaccination could not be obtained in all cases due to inability to recall by the patient or absence of the BCG scar. It is also known that vaccine-induced reactions tend to wane over time and are unlikely to persist over 10 years. [3],[4]

Group C had five out of 21 cases positive for the quantiferon TB gold test. Among the 21 cases in Group C, PPD positivity was seen in two cases. Only one case out of the 21 cases had both PPD and Quanti feron TB gold test positive while 15 of the 21 cases had both tests negative. In Group D, 28 cases out of 39 cases had both tests positive and had intraocular tuberculosis (response to antitubercular therapy). As a result, the specificity and sensitivity remains unchanged.

 
  References Top

1.
Chhablani J. Comment on: Utility of QuantiFERON Tuberculosis gold test in a south Indian patient population of ocular inflammation. Indian J Ophthalmol 2010;58:346.  Back to cited text no. 1
  Medknow Journal  
2.
Babu K, Satish V, Satish S, Subbakrishna DK, Abraham MP, Murthy KR. Utility of QuantiFERON TB gold test in a south Indian patient population of ocular inflammation. Indian J Ophthalmol 2009;57:427-30.  Back to cited text no. 2
[PUBMED]  Medknow Journal  
3.
Centers for Disease Control and Prevention. Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 1995;44:19-34.   Back to cited text no. 3
[PUBMED]  [FULLTEXT]  
4.
Bansal R, Gupta A, Gupta V, Dogra MR, Bambery P, Arora SK. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol 2008;146:772-9.  Back to cited text no. 4
[PUBMED]  [FULLTEXT]  




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed1061    
    Printed11    
    Emailed0    
    PDF Downloaded104    
    Comments [Add]    

Recommend this journal